Within this context, metabolic stability may depend on proportionality between substrate availability and pharmacologically induced metabolic demand
Late-stage fixed-dose combinations of GLP-1/SGLT-2 relaxations also exploit the synergistic effects of augmented insulin secretion, suppressed glucagon, and delayed gastric emptying (GLP-1) along with urinary glucose excretion and cardiovascular protection (SGLT-2 inhibitors)
Review your blood work with your doctor Lab work is necessary
Acknowledgements: CRAM:Research Ireland:13/RC/2073_P2,SENSOME Disclosure of interest: All authors:nothing to disclose 1 - ICH & SAH 02.00 - INTRACRANIAL HEMORRHAGE - 02.01 - INTRACEREBRAL HAEMORRHAGE P740 - ESOC25-498 HEMATOMA LOCATION AND SYMPTOM ONSET TO SAMPLING ARE PREDICTORS OF GFAP RELEASE INTO PLASMA IN ACUTE INTRACEREBRAL HEMORRHAGE Sabina Zylyftari 1 , Love-Preet Kalra 1 , Sebastian Luger 1 , Stephan Barthelmes 1 , Kristaps Blums 1 , Christian Foerch 1 1 RKH Klinikum Ludwigsburg, Ludwigsburg, Germany Background and Aims: GFAP (glial fibrillary acidic protein) is a promising biomarker for distinguishing intracerebral hemorrhage (ICH) from ischemic stroke in the prehospital phase
